Skip to main content

Table 2 Patient characteristics after 4 months (visit 3)

From: Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study

 

Oral

Glargine

NPH Insulin

all

p

N

13

20

22

55

 

BMI (kg/m 2 )

29.5+/-4.9

32.8+/-5.9

32.7+/-7.5

32.0+/-6.4

0.294

HbA1c (%)

6.8+/-0.8

6.6+/-0.7

6.7+/-0.6

6.7+/-0.7

0.614

Fasting Glucose (mg/dl)

139.5+/-36.0

136.5+/-49.9

119.4+/-32.4

130.2+/-40.5

0.264

Serum Creatinin (mg/dl)

0.8+/-0.2

0.9+/-0.2

0.9+/-0.2

0.9+/-0.2

0.647

Triglycerides (mg/dl)

166.5+/-93.8

178.7+/-112.8

205.2+/-203.2

186.4+/-150.9

0.741

HDL-cholesterol (mg/dl)

52.6+/-17.4

46.1+/-10.1

45.9+/-10.3

47.5+/-12.3

0.240

LDL-cholesterol (mg/dl)

106.2+/-31.6

85.7+/-38.4

105.3+/-25.2

98.3+/-33.0

0.108

Hemoglobin (g/dl)

14.0+/-1.0

13.7+/-1.4

14.2+/-1.5

14.0+/-1.3

0.494

Leukocyte count /nl

6.6+/-1.6

7.8+/-2.3

7.6+/-1.8

7.4+/-2.0

0.250

Intima media thickness (mm)

0.82+/-0.11

0.74+/-0.10

0.76+/-0.14

0.76+/-0.12

0.153

Skin microvascular function (%)

564.9+/-306.5

514.5+/-329.7

487.7+/-229.6

515.7+/-283.8

0.746